Michele Bianchini

1.6k citations

45 papers · 1.2k indexed · h-index 19

Impact in

Hematology top 5%
- Chronic Myeloid Leukemia Treatments
Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology

Papers in

Hematology 21
- Chronic Myeloid Leukemia Treatments 16
- Acute Myeloid Leukemia Research 8
Genetics 15
- Chronic Lymphocytic Leukemia Research 13

Co-authors: José Mordoh Estrella Mariel Levy Juan Martín Arriaga Alicia Bravo María Marcela Barrio Cinzia Zucchini Luisa Valvassori María P. Roberti
Journals: International Journal of Oncology (3 papers)Innate Immunity (2 papers)Human Pathology (2 papers)Journal of Translational Medicine (2 papers)Blood Cells Molecules and Diseases (2 papers)
Partner nations: Argentina Italy United States

In The Last Decade

Michele Bianchini

45 papers receiving 1.2k citations

Peers

Countries citing papers authored by Michele Bianchini

Since Specialization

Citations

This map shows the geographic impact of Michele Bianchini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Bianchini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Bianchini more than expected).

Fields of papers citing papers by Michele Bianchini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Bianchini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Bianchini. The network helps show where Michele Bianchini may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michele Bianchini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michele Bianchini Line = papers co-authored together Michele Bianchini links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Treatment-free remission in patients with chronic myeloid leukemia: recommendations of the LALNET expert panel Blood Advances ·Carolina Pavlovsky, Kristina Strasunskiene, Kátia Bórgia Barbosa Pagnano, René David Morales Basulto, Coleman Ja, Michele Bianchini, Carla Boquimpani, J. Wyn Roberts, 富本信, 叶康生, Vaneuza Araújo Moreira Funke, Л.Н. Захаров, Luís Felipe Schroeder, Luis Meillón, Beatriz Moiraghi, Inna L. Malinka, Chaocheng Zheng, 佳子相沢, B E Colley, Jörge E. Cortes	2021	13
2	miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool Frontiers in Pharmacology ·Han Xing, Raymond Putra Edfran, Jiro Alcala, Carolina Furtado, S Linder-Aronson, Patricio Yankilevich, Huang Zheng-sing, 林義正, 王婉华, Beatriz Moiraghi, Song Junya, Carolina Pavlovsky, René David Morales Basulto, Anisa Dian Maryana, ADEL MOHAMMED MOHAMMED REDHWAN, Irene Larripa, Ilana Zalcberg, José Mordoh, Peter Valent, Michele Bianchini	2021	10
3	Metallothionein 1G promotes the differentiation of HT-29 human colorectal cancer cells Oncology Reports ·Juan Martín Arriaga, Alicia Bravo, José Mordoh, Michele Bianchini	2017	18
4	Metallothionein 1G and Zinc Sensitize Human Colorectal Cancer Cells to Chemotherapy Molecular Cancer Therapeutics ·Juan Martín Arriaga, Angela Greco, José Mordoh, Michele Bianchini	2014	39
5	Improved Diagnosis of the Transition to JAK2V617F Homozygosity: The Key Feature for Predicting the Evolution of Myeloproliferative Neoplasms PLoS ONE ·Qianshun Xu, Carlos Daniel De Brasi, Michele Bianchini, Alice Conner, 上原赫, Ilana Zalcberg, Irene Larripa	2014	2
6	CAMKIIγ, HSP70andHSP90transcripts are differentially expressed in chronic myeloid leukemia cells from patients with resistant mutated disease Leukemia & lymphoma ·B. T. King, Carlos Daniel De Brasi, Rizan Setyo Nugroho, Edwin C. Surrency, Michele Bianchini, Irene Larripa	2013	7
7	Combined metallothioneins and p53 proteins expression as a prognostic marker in patients with Dukes stage B and C colorectal cancer Human Pathology ·Juan Martín Arriaga, H Koga, Thaer Alhallak, В. О. Клыгин, Julia Sauer, Fernando Sánchez Loria, 傅丕毅, Eduardo Huertas, María P. Roberti, Yamila Rocca, Mariana Aris, María Marcela Barrio, Clement Montague, Estrella Mariel Levy, José Mordoh, Michele Bianchini	2012	12
8	Early detection and quantification of mutations in the tyrosine kinase domain of chimericalBCR–ABL1gene combining high-resolution melting analysis and mutant-allele specific quantitative polymerase chain reaction Leukemia & lymphoma ·Rizan Setyo Nugroho, Michele Bianchini, Ángeles Gil, Kang Chen, Edwin C. Surrency, Irene Larripa	2012	4
9	Protein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude mice Cancer Biology & Therapy ·María Paula Roberti, Juan Martín Arriaga, Michele Bianchini, Denis Honorato Costa, Alicia Bravo, Estrella Mariel Levy, José Mordoh, María Marcela Barrio	2012	39
10	IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients Breast Cancer Research and Treatment ·María P. Roberti, Yamila Rocca, Mora Amat, M. Betina Pampena, Бабаева Ольга Алексеевна, В.М. Дмитриев, Miki AKATSUKA, W.R. Blosser, Juan Martín Arriaga, Michele Bianchini, María Marcela Barrio, Alicia Bravo, 변병걸, Reinaldo Chacón, José Mordoh, Estrella Mariel Levy	2012	48
11	Metallothionein expression in colorectal cancer: relevance of different isoforms for tumor progression and patient survival Human Pathology ·Juan Martín Arriaga, Estrella Mariel Levy, Alicia Bravo, В. О. Клыгин, Mora Amat, Mariana Aris, Julia Sauer, Luisina Bruno, María Paula Roberti, Fernando Sánchez Loria, Alejandro Pairola, Eduardo Huertas, José Mordoh, Michele Bianchini	2011	43
12	BAX/BCL-XL gene expression ratio inversely correlates with disease progression in chronic myeloid leukemia Blood Cells Molecules and Diseases ·Qianshun Xu, Carlos Daniel De Brasi, Michele Bianchini, Alice Conner, Beatriz Moiraghi, Edwin C. Surrency, Irene Larripa	2010	12
13	A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression Journal of Translational Medicine ·Erika M. von Euw, María Marcela Barrio, David Furman, Estrella Mariel Levy, Michele Bianchini, Isabelle Péguillet, Olivier Lantz, Amparo Mifsud Giner, Mohammad Yawar Wani, Matías Chacón, Cassian Yee, Rosa Wainstok, José Mordoh	2008	58
14	Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer International Journal of Oncology ·Estrella Mariel Levy, Michele Bianchini, Erika von Euw, Carise Elisane Schmidt, Alicia Bravo, David Furman, 변병걸, 直垦田, 清水大輔, Cinzia Zucchini, Luisa Valvassori, José Mordoh	2008	100
15	Specific assessment of BCR–ABL transcript overexpression and imatinib resistance in chronic myeloid leukemia patients European Journal Of Haematology ·Michele Bianchini, Carlos Daniel De Brasi, Alice Conner, B. T. King, Edwin C. Surrency, Irene Larripa	2008	13
16	Sorting Nexin 1 Down-Regulation Promotes Colon Tumorigenesis Clinical Cancer Research ·Lananh Nguyen, Matthew S. Holdren, 神谷直樹, Momoko Furuya, Michele Bianchini, Estrella Mariel Levy, José Mordoh, Yongfei Chai, WU Hui-yao, Jean S. Campbell, W. Tony Parks	2006	33
17	cDNA microarray study to identify expression changes relevant for apoptosis in K562 cells co-treated with amifostine and imatinib Cancer Chemotherapy and Pharmacology ·Michele Bianchini, Giovanni Martinelli, Matteo Renzulli, Marcela González Cid, Irene Larripa	2006	8
18	Identification of candidate genes involved in the reversal of malignant phenotype of osteosarcoma cells transfected with the liver/bone/kidney alkaline phosphatase gene Bone ·Cinzia Zucchini, Michele Bianchini, Luisa Valvassori, Stefania Perdichizzi, Stefania Benini, Maria Cristina Manara, Rossella Solmi, Pierluigi Strippoli, Piero Picci, Paolo Carinci, Katia Scotlandi	2004	30
19	Novel FLT3 point mutation in acute myeloid leukaemia The Lancet Oncology ·Pier Paolo Piccaluga, Michele Bianchini, Giovanni Martinelli	2003	9
20	APC Senses Cell–Cell Contacts and Moves to the Nucleus upon Their Disruption Biochemical and Biophysical Research Communications ·Mariana Brocardo, Michele Bianchini, M. Radrizzani, Natama Hamtandi Magloire, Andrea Dugour, A Pedro, Kit Harrington, Tomás A. Santa‐Coloma	2001	13

About Michele Bianchini

Michele Bianchini is a scholar working on Hematology, Genetics, Rheumatology, Immunology and Oncology, having authored 45 papers that have together received 1.2k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (16 papers), Chronic Lymphocytic Leukemia Research (13 papers), Acute Myeloid Leukemia Research (8 papers), Eosinophilic Disorders and Syndromes (8 papers), Immunotherapy and Immune Responses (7 papers), Immune Cell Function and Interaction (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Trace Elements in Health (4 papers). The work is most often cited by research in Hematology (236 citations), Immunology (432 citations), Oncology (421 citations), Genetics (159 citations) and Cancer Research (117 citations). Michele Bianchini has collaborated with scholars based in Argentina, Italy and United States. Frequent co-authors include José Mordoh, Estrella Mariel Levy, Juan Martín Arriaga, Alicia Bravo, María Marcela Barrio, Cinzia Zucchini, Luisa Valvassori, María P. Roberti, Yamila Rocca and David Furman. Their work appears in journals such as International Journal of Oncology, Innate Immunity, Human Pathology, Journal of Translational Medicine and Blood Cells Molecules and Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact